TR201108087A2 - Single unit solid dosage forms. - Google Patents

Single unit solid dosage forms.

Info

Publication number
TR201108087A2
TR201108087A2 TR2011/08087A TR201108087A TR201108087A2 TR 201108087 A2 TR201108087 A2 TR 201108087A2 TR 2011/08087 A TR2011/08087 A TR 2011/08087A TR 201108087 A TR201108087 A TR 201108087A TR 201108087 A2 TR201108087 A2 TR 201108087A2
Authority
TR
Turkey
Prior art keywords
dosage forms
single unit
solid dosage
unit solid
donepezil
Prior art date
Application number
TR2011/08087A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/08087A priority Critical patent/TR201108087A2/en
Publication of TR201108087A2 publication Critical patent/TR201108087A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)

Abstract

Mevcut buluş donepezil veya farmasötik açıdan uygun herhangi bir türevini ve ginkgo biloba özütü içeren tek birim katı dozaj formlarına ve bu tarz dozaj formlarının alzheimer tedavisinde kullanımına ilişkindir.The present invention relates to single unit solid dosage forms comprising donepezil or any pharmaceutically acceptable derivative thereof and ginkgo biloba extract, and the use of such dosage forms in the treatment of Alzheimer's.

TR2011/08087A 2010-08-25 2011-08-12 Single unit solid dosage forms. TR201108087A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TR2011/08087A TR201108087A2 (en) 2010-08-25 2011-08-12 Single unit solid dosage forms.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/07109A TR201007109A2 (en) 2010-08-25 2010-08-25 Single unit dosage forms.
TR2011/08087A TR201108087A2 (en) 2010-08-25 2011-08-12 Single unit solid dosage forms.

Publications (1)

Publication Number Publication Date
TR201108087A2 true TR201108087A2 (en) 2012-07-23

Family

ID=44947168

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2010/07109A TR201007109A2 (en) 2010-08-25 2010-08-25 Single unit dosage forms.
TR2011/08087A TR201108087A2 (en) 2010-08-25 2011-08-12 Single unit solid dosage forms.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TR2010/07109A TR201007109A2 (en) 2010-08-25 2010-08-25 Single unit dosage forms.

Country Status (2)

Country Link
TR (2) TR201007109A2 (en)
WO (1) WO2012026904A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014007774A1 (en) * 2012-07-02 2014-01-09 Mahmut Bilgic Water soluble formulations comprising a piperidine derivative active agent

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI95572C (en) 1987-06-22 1996-02-26 Eisai Co Ltd Process for the preparation of a medicament useful as a piperidine derivative or its pharmaceutical salt

Also Published As

Publication number Publication date
TR201007109A2 (en) 2012-03-21
WO2012026904A1 (en) 2012-03-01

Similar Documents

Publication Publication Date Title
ZA202202711B (en) Sustained-release dosage forms of ruxolitinib
BR112015020466A8 (en) cdc7 inhibitors, their uses, and pharmaceutical composition
MX2020010535A (en) Methods of treating cancer.
UA108198C2 (en) Substituted 2-acetamido-5-aryl-l, 2,4-triazolones and their use
TN2015000076A1 (en) Methods of treating alzheimer's disease and pharmaceutical compositions thereof
UA109650C2 (en) BIS-ARLYZED ARILTRIAZOLONS AND THEIR APPLICATIONS
WO2012080727A3 (en) Casein kinase 1delta (ck1delta) inhibitors
IL216599A (en) 1,4-disubstituted phthalazine derivatives, pharmaceutical compositions comprising them and use thereof in the treatment of cancer
MY157673A (en) Pharmaceutical compositions comprising hydromorphone and naloxone
MX2016002580A (en) Combination of an alk inhibitor and a cdk inhibitor for the treatment of cell proliferative diseases.
IN2012DN05186A (en)
CL2014003325A1 (en) Compounds derived from difluoro-hexahydro-cyclopentaoxacinyls and difluoro-hexahydro-benzooxacinyls, bace 1 inhibitors; pharmaceutical composition; and its use in the treatment of diseases with elevated levels of beta-amyloid, such as Alzheimer's disease
CL2014003607A1 (en) Compounds derived from benzodioxol, acetylcholinesterase inhibitors; Preparation method; intermediary compounds; pharmaceutical composition; and use in the prevention or treatment of Alzheimer's disease.
CL2012001940A1 (en) Compositions comprising extracts of andrographis paniculata combined with extracts of ginkgo biloba complexed with phospholipids; and its use in the preparation of a medicament for the treatment of Alzheimer's and multiple sclerosis.
MY164998A (en) Isoquinolinone derivatives as nk3 antagonists
TR201007110A2 (en) Combinations with synergistic effects
MX2015013755A (en) Pharmaceutical formulation for use in the treatment and/or prevention of restenosis.
IN2014DN09437A (en)
TR201108087A2 (en) Single unit solid dosage forms.
TR201007111A2 (en) Compositions showing synergistic effects.
WO2014023869A3 (en) Therapeutic use of cd44 inhibitor agents against human acute lymphoblastic leukaemia (all)
TR200906322A2 (en) Granules with improved solubility and stability properties.
PH12019501070A1 (en) Sustained-release dosage forms of ruxolitinib
TR201204568A2 (en) Effervescent tablet containing galantamine.
TH136241B (en) Components for treatment and / or prevention of skin disorders.